$13.85
-0.005-0.04%
Last update: Nov 10, 10:23 AM
Organon & Co
OGNNYSE
Organon & rose 79.6% from $7.71 to $13.85, ahead of the S&P 500's +10.5%. Its worst day was Feb 12 (−8.2%), and its low came Mar 30 at $5.70.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $1.01 beat the $0.92 estimate on $1.6B revenue (est. $1.6B); FY revenue guidance of $6.2B–$6.3B against the $6.3B consensus.
0.0% · S&P 500 +1.6%
Story events cover the past 12 months · Times ET
EPS of $0.63 missed the $0.72 estimate on $1.5B revenue (est. $1.5B); FY revenue guidance of $6.2B against the $6.1B consensus.
−8.2%, the year's worst day · S&P 500 −1.5%
Organon & closed at its lowest level of the year, 26.1% below where the year started.
−2.4% · S&P 500 −0.3%
Organon & shares rose 27.8%, while the S&P 500 fell 0.1%.
+27.8% · S&P 500 −0.1%
EPS of $0.71 missed the $0.84 estimate on $1.5B revenue (est. $1.5B).
−0.7% · S&P 500 +1.0%
EPS of $0.85 missed the $1.03 estimate on $1.6B revenue (est. $1.6B).
0.0% · S&P 500 +0.7%
EPS of $0.94 missed the $0.95 estimate on $1.6B revenue (est. $1.6B).
+0.2% · S&P 500 −1.8%
Where it ended: a close of $13.85 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $0.72, revenue est. $1.5B).
As of the Nov 9, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OGN and SPY from Benzinga historical bars. Not investment advice.
